Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 15 |
| Active Pipeline (Recruiting Now) | 2 (0) |
| Completed vs Stopped Early | 8 / 1 (6.7%) |
| Median Closed Actual Enrollment | 273 participants |
| Physical Hospital Site Disclosure | 99.7% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 1 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Velocity Clinical Research (West Jordan) | West Jordan, UT | 2 |
| University of Alabama at Birmingham | Birmingham, AL | 2 |
| Siriraj Hospital | Bangkok | 2 |
Explore interactive annual charts and M&A subsidiary rollups in the LG Chem Interactive Dossier, benchmark peers in Infectious Disease and Vaccines, or review the Healthcare Price & Patent Cliff Crosswalk.